From applied therapeutics, trying to arrest visceral leishmaniasis during her PhD, to working on malaria vaccination during her post-doctoral studies, Debabani has always been pushed by the urge to find better treatments for diseases. In her new role at Mestastop, she is looking into the modalities of EM hybrids.